HDMT
hDMT is a consortium dedicated to advancing organ-on-chip technology and human disease models. Its mission is to enhance understanding of human biology and improve health management through dynamic human models that mimic parts of the human body. The institute fosters multidisciplinary collaboration, standardization, and practical application of these models, supported by a network of partner organizations including universities, medical centers, and industry partners. hDMT actively promotes research, standardization, and valorization in the field of organ-on-chip technology, aiming to create accessible, tailored models for end users worldwide. It collaborates with numerous partners such as Utrecht University, Amsterdam UMC, Wageningen University, TU Eindhoven, TNO, MUMC+, LUMC, TU Delft, Leiden University, Radboud UMC, Erasmus MC, VU University, Leiden University of Applied Sciences, and UMCU.
Industries
Nr. of Employees
small (1-50)
Products
hDMT INFRA (national research infrastructure)
A national infrastructure project providing coordinated access to expertise, service centers and training for human dynamic model development and translation.
NXTGEN Hightech Biomed / One-Stop-Shop
Consortium project to create an ecosystem connecting developers, suppliers and end-users of biomedical innovations and high-tech biomedical production systems.
VHP4Safety (Virtual Human Platform for Safety Assessment)
Platform project that aims to transform chemical and pharmaceutical safety evaluation by developing human-relevant in vitro methods to reduce animal testing.
LYMPHCHIP
Consortium project developing organ-on-chip models with integrated lymphatic components to study immune-related diseases and precision tools for immunology research.
SMART OoC and Moore4Medical (open technology platform projects)
Collaborative projects focused on open technology platforms and demonstrating technological relevance and economic benefits of interoperable device platforms in medical device development.
NOCI (national organ-on-chip initiative)
Long-term coordinated research initiative to develop platforms that improve prediction of drug effects using human stem cells and microchip technologies.
hDMT INFRA (national research infrastructure)
A national infrastructure project providing coordinated access to expertise, service centers and training for human dynamic model development and translation.
NXTGEN Hightech Biomed / One-Stop-Shop
Consortium project to create an ecosystem connecting developers, suppliers and end-users of biomedical innovations and high-tech biomedical production systems.
VHP4Safety (Virtual Human Platform for Safety Assessment)
Platform project that aims to transform chemical and pharmaceutical safety evaluation by developing human-relevant in vitro methods to reduce animal testing.
LYMPHCHIP
Consortium project developing organ-on-chip models with integrated lymphatic components to study immune-related diseases and precision tools for immunology research.
SMART OoC and Moore4Medical (open technology platform projects)
Collaborative projects focused on open technology platforms and demonstrating technological relevance and economic benefits of interoperable device platforms in medical device development.
NOCI (national organ-on-chip initiative)
Long-term coordinated research initiative to develop platforms that improve prediction of drug effects using human stem cells and microchip technologies.
Services
Support for project ideation, proposal writing, advisory board participation and connecting researchers with funding opportunities and partners.
Provision and coordination of infrastructure elements (test centers, training centers, service centers of expertise) to support model development, qualification and training.
Facilitation of standards development, creation of roadmaps and engagement with standards committees to enable harmonization of methods and qualification paths.
Organization of conferences, thematic working groups, summer schools, webinars and hands-on workshops focused on organ-on-chip and related microphysiological technologies.
Regular newsletters, publication archives and community communication channels to share results, opportunities and community news.
Access to and coordination of a national and international network of academic and research partners to enable collaborations, knowledge exchange and translational partnerships.
Support for project ideation, proposal writing, advisory board participation and connecting researchers with funding opportunities and partners.
Provision and coordination of infrastructure elements (test centers, training centers, service centers of expertise) to support model development, qualification and training.
Facilitation of standards development, creation of roadmaps and engagement with standards committees to enable harmonization of methods and qualification paths.
Organization of conferences, thematic working groups, summer schools, webinars and hands-on workshops focused on organ-on-chip and related microphysiological technologies.
Regular newsletters, publication archives and community communication channels to share results, opportunities and community news.
Access to and coordination of a national and international network of academic and research partners to enable collaborations, knowledge exchange and translational partnerships.
Expertise Areas
- Organ-on-chip and microphysiological systems
- iPSC-derived cell models and organoids
- Microfluidics and device fabrication
- Biomaterials for tissue engineering
Key Technologies
- Microfluidic organ-on-chip platforms
- Induced pluripotent stem cell (iPSC) models
- 3D organoids
- Perfused vasculature-on-chip
News & Updates
An event scheduled from August 31 to September 4, 2025.
An event scheduled from September 15 to September 19, 2025.
An event scheduled for September 15, 2025.
An event scheduled from November 18 to November 19, 2025.
An article about a grant awarded for developing a midbrain organoid model to study Parkinson’s disease.
Announcement of the appointment of Jetty van Ginkel as the new Managing Director.
An event scheduled from August 31 to September 4, 2025.
An event scheduled from September 15 to September 19, 2025.
An event scheduled for September 15, 2025.
An event scheduled from November 18 to November 19, 2025.
An article about a grant awarded for developing a midbrain organoid model to study Parkinson’s disease.
Announcement of the appointment of Jetty van Ginkel as the new Managing Director.